Published in
Wiley, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 5(12), 2020
DOI: 10.1002/wnan.1633
Links
Tools
Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls
Journal article published in 2020 by
Wim H. de Jong,
Christina Giannakou 
,
Jan Willem van der Laan,
Henk van Loveren,
Margriet V. D. Z. Park ,
Irene E. M. Bosselaers ,
Wim H. Jong ,
Jan Willem Laan ,
Henk Loveren ,
Rob J. Vandebriel ,
Robert E. Geertsma
,
Jan Willem van der Laan,
Henk van Loveren,
Margriet V. D. Z. Park ,
Irene E. M. Bosselaers ,
Wim H. Jong ,
Jan Willem Laan ,
Henk Loveren ,
Rob J. Vandebriel ,
Robert E. Geertsma
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 